Advertisement
BDX vs EPOL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Hold and EPOL is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDX’s FA Score shows that 1 FA rating(s) are green while.
- BDX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDX’s TA Score shows that 3 TA indicator(s) are bullish.
- BDX’s TA Score: 3 bullish, 7 bearish.
Price Growth
BDX (@Pharmaceuticals: Other) experienced а +1.36% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.29%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +14.72%.
Reported Earning Dates
BDX is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (-0.29% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
BDX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 82 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BDX | EPOL | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 62% | N/A |
| Stochastic ODDS (%) | 3 days ago 46% | 3 days ago 87% |
| Momentum ODDS (%) | 3 days ago 45% | 3 days ago 80% |
| MACD ODDS (%) | 3 days ago 49% | 3 days ago 83% |
| TrendWeek ODDS (%) | 3 days ago 42% | 3 days ago 86% |
| TrendMonth ODDS (%) | 3 days ago 36% | 3 days ago 84% |
| Advances ODDS (%) | 5 days ago 44% | 11 days ago 86% |
| Declines ODDS (%) | 3 days ago 37% | 9 days ago 84% |
| BollingerBands ODDS (%) | 3 days ago 49% | N/A |
| Aroon ODDS (%) | 3 days ago 38% | 3 days ago 89% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ONOF | 36.94 | 0.20 | +0.54% |
| Global X Adaptive US Risk Management ETF | |||
| IBB | 154.19 | 0.77 | +0.50% |
| iShares Biotechnology ETF | |||
| TJAN | 27.03 | 0.05 | +0.17% |
| Innovator Equity Defined Protection ETF - 2 Yr to January 2027 | |||
| IBII | 26.13 | -0.06 | -0.21% |
| iShares iBonds Oct 2032 Term Tips ETF | |||
| EYLD | 37.62 | -0.15 | -0.40% |
| Cambria Emerging Shareholder Yield ETF | |||
BDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with TFX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then TFX could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | +2.07% | ||
| TFX - BDX | 51% Loosely correlated | +3.43% | ||
| TMO - BDX | 50% Loosely correlated | +0.40% | ||
| CNMD - BDX | 48% Loosely correlated | +0.51% | ||
| RVTY - BDX | 45% Loosely correlated | -0.54% | ||
| STE - BDX | 44% Loosely correlated | -0.04% | ||
More | ||||
EPOL and
Correlation & Price change
A.I.dvisor indicates that over the last year, EPOL has been loosely correlated with TXT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if EPOL jumps, then TXT could also see price increases.
| Ticker / NAME | Correlation To EPOL | 1D Price Change % | ||
|---|---|---|---|---|
| EPOL | 100% | +0.27% | ||
| TXT - EPOL | 44% Loosely correlated | -0.36% | ||
| MRC - EPOL | 41% Loosely correlated | N/A | ||
| NEU - EPOL | 29% Poorly correlated | -1.18% | ||
| BDX - EPOL | 19% Poorly correlated | +2.07% | ||
| EAT - EPOL | 17% Poorly correlated | -0.34% | ||
More | ||||